Fate Therapeutics Eulerpool News

Fate Therapeutics Eulerpool News

Fate Therapeutics Stock News

Fate Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Fate Therapeutics news here.

• September 12 ·

  Yahoo
  Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference
• September 12 ·

  Yahoo
  Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
• August 22 ·

  Yahoo
  Broker Revenue Forecasts For Fate Therapeutics, Inc. (NASDAQ:FATE) Are Surging Higher
• August 20 ·

  TipRanks
  Fate Therapeutics’ Promising Outlook: Buy Rating on Innovative Cell Therapy Programs FT819 and FT522
• August 18 ·

  TipRanks
  Fate Therapeutics (FATE) Gets a Hold from Stifel Nicolaus
• August 16 ·

  Yahoo
  All You Need to Know About Fate Therapeutics (FATE) Rating Upgrade to Buy
• August 16 ·

  TipRanks
  Fate Therapeutics: Hold Rating Amidst Steady Q2 Financials and Clinical Progress
• August 15 ·

  Yahoo
  Fate Therapeutics Second Quarter 2024 Earnings: Beats Expectations
• August 14 ·

  Yahoo
  FATE Q2 Earnings Beat on Lower Expenses, Collaboration Revenues Grow
• August 14 ·

  TipRanks
  Wedbush Reaffirms Their Hold Rating on Fate Therapeutics (FATE)